Physician profile
Congrong Lin
NPI 1457643306
$5,574.56
in general payments reported to CMS, 2019-2025
17 companies · $903 in 2025
The $903 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2020: $104 · 2021: $890 · 2022: $1,165 · 2023: $1,052 · 2024: $837 · 2025: $903.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,712 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,711.79 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,066.98 | 2019-2025 | Aveir, Gallant |
| Janssen Pharmaceuticals, INC | $1,018.55 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $731.40 | 2019-2025 | Camzyos, Eliquis |
| Sanofi-Aventis U.S. LLC | $567.29 | 2020-2024 | |
| Actelion Pharmaceuticals US, INC. | $372.53 | 2022-2025 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $367.66 | 2022-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $346.65 | 2019-2024 | |
| Pfizer INC. | $314.66 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $195.21 | 2022-2023 | Jardiance |
| Edwards Lifesciences Corporation | $190.50 | 2020-2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $158.79 | 2019-2024 | Watchman Flx, Watchman |
| Biotronik INC. | $72.85 | 2022-2024 | Amvia Edge, Acticor 7 Vr-T Dx |
| Gilead Sciences, INC. | $60.00 | 2019 | |
| Glaxosmithkline, LLC. | $41.36 | 2025 | Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $32.31 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $21.25 | 2021 | |
| Medtronic, INC. | $16.57 | 2023 | Azure Xt Dr Mri Surescan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Congrong Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.